4.1 Article

A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/13651501.2012.755206

关键词

Obsessive-compulsive; longitudinal; prevalence; incidence; epidemiology

资金

  1. Swiss National Science Foundation [32-50881.97]
  2. Lundbeck
  3. Glaxo-SmithKline
  4. Astra Zeneca
  5. Wellcome
  6. Cephalon
  7. ECNP
  8. Servier
  9. Janssen
  10. Bristol Myers Squibb
  11. Jazz
  12. AstraZeneca
  13. Wyeth
  14. International College of OC Spectrum Disorders

向作者/读者索取更多资源

Objective. Prospective longitudinal studies of obsessive-compulsive disorder (OCD) and sub-diagnostic obsessive-compulsive symptomatology in the non-clinical population, using age-defined cohorts, are rare. This study aimed to investigate the effect of OC symptoms on distress and psychosocial function and the effect of early-onset OC symptoms. Methods. 591 subjects drawn from the general population of Zurich, Switzerland were interviewed seven times between 1979 (at age 20/21) and 2008 (age 49/50). Data for socio-demographic variables and psychosocial impairment was also collected and compared with a control-group without OC symptoms drawn from the same population. Results. The unweighted cumulative one-year rate of OCD in this sample was 5.1% and 21.7% reported some degree of clinically-relevant OC symptomatology (OCD or OCS). OCD appeared more prevalent in females whereas OCS and OC symptoms were more prevalent in males. The weighted cumulative prevalence rates, representative of the general population, for OCD, OCS and OC symptoms were 3.5%, 9.7%, and 11.2%, respectively. We could not identify OCD occurring before the age of 10 years, though sub-threshold cases were reported as early as age 2 years, whereas by the age of 22 years, around two thirds of OCD cases had emerged and no new cases developed OCD aft er around 37 years. Males were statistically significantly younger than females at onset of any OC symptomatology. Conclusions. Clinically-relevant OC syndromes start early and are associated with substantial distress, treatment-seeking activity and in the case of OCD, functional disability.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Psychology, Developmental

Patterns of internalizing symptoms and disability functioning in children and adolescents

Simone Amendola, Michael P. Hengartner, Valentina Spensieri, Luciano Grillo, Rita Cerutti

Summary: Despite previous studies, there is little consistent knowledge on the co-occurrence patterns of somatic, depressive, and anxiety symptoms in children and adolescents. This study used cluster analysis to examine these patterns, finding that participants with high levels of depressive and anxiety symptoms reported greater functional disability due to somatic symptoms. Significant differences were also shown in gender and age among the four clusters identified.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2022)

Letter Neurosciences

Learning about the course of suicidal behavior but not about the effects of SSRIs

Martin Ploederl, Michael P. Hengartner

NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychology, Multidisciplinary

Overlap between general factors of psychopathology and personality: They share associations with daily life functioning and communication style

Dimitri van der Linden, Curtis S. Dunkel, Peter Prinzie, Misa Yamanaka-Altenstein, Agnes von Wyl, Michael P. Hengartner

Summary: This study examined the overlap between higher-order factors of personality and psychopathology, and their relationship with daily life functioning and communication style. The findings suggest that the overlap between these factors may contribute to lower life functioning and less social effectiveness.

CURRENT PSYCHOLOGY (2023)

Article Clinical Neurology

Longitudinal reciprocal associations between depression, anxiety, and substance use disorders over three decades of life

Simone Amendola, Michael Pascal Hengartner, Vladeta Ajdacic-Gross, Jules Angst, Wulf Roessler

Summary: This study examined the longitudinal associations between depressive, anxiety, and substance use disorders. The findings revealed reciprocal relationships between these disorders and highlighted gender differences, with females being more susceptible to depressive and anxiety disorders, and males being more vulnerable to substance use disorders. Early treatment and comprehensive psychosocial interventions are crucial in preventing chronicity and further maladjustment.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Review Biochemistry & Molecular Biology

The serotonin theory of depression: a systematic umbrella review of the evidence

Joanna Moncrieff, Ruth E. Cooper, Tom Stockmann, Simone Amendola, Michael P. Hengartner, Mark A. Horowitz

Summary: The serotonin hypothesis of depression, which suggests that depression is caused by lowered serotonin activity or concentrations, lacks consistent evidence based on the synthesis and evaluation of research in this field. This umbrella review found no substantial association between serotonin and depression, while suggesting that long-term antidepressant use may reduce serotonin concentration.

MOLECULAR PSYCHIATRY (2023)

Article Biochemistry & Molecular Biology

Increased suicide risk among younger women in winter during full moon in northern Europe. An artifact or a novel finding?

Martin Ploederl, Joakim Westerlund, Sebastian Hokby, Gergo Hadlaczky, Michael Pascal Hengartner

Summary: The available evidence suggests that moon phases have no impact on suicidal behavior. A recent Finnish study reporting elevated suicide rates during full moon among premenopausal women in winter could not be replicated in an Austrian study. The present study in Sweden, geographically more comparable to Finland, also found no correlation between full moon and suicide rates, supporting the null hypothesis.

MOLECULAR PSYCHIATRY (2023)

Review Clinical Neurology

Estimating Risk of Antidepressant Withdrawal from a Review of Published Data

Mark Abie Horowitz, Adele Framer, Michael P. Hengartner, Anders Sorensen, David Taylor

Summary: The brain's adaptation to drugs can predict withdrawal symptoms upon cessation. Physical dependence to antidepressants may occur in some patients, and factors such as duration of use, dosage, and specific drugs can influence the risk of withdrawal effects. Further research is needed to improve prediction tools and understand the adaptability of long-term antidepressant use.

CNS DRUGS (2023)

Letter Neurosciences

No Clear Evidence of Reduced Brain Serotonin Release Capacity in Patients With Depression

Michael P. Hengartner, Martin Ploederl

BIOLOGICAL PSYCHIATRY (2023)

Letter Biochemistry & Molecular Biology

The serotonin hypothesis of depression: both long discarded and still supported?

Joanna Moncrieff, Ruth E. E. Cooper, Tom Stockmann, Simone Amendola, Michael P. P. Hengartner, Martin Ploderl, Mark A. A. Horowitz

MOLECULAR PSYCHIATRY (2023)

Article Endocrinology & Metabolism

Sexual attraction to visual sexual stimuli in association with steroid hormones across menstrual cycles and fertility treatment

Viola Schon, Michael P. Hengartner, Enrico Tronci, Toni Mancini, Fabian Ille, Susanna Roblitz, Tillmann Kruege, Brigitte Leeners

Summary: This study investigated the relationship between steroid hormones and women's sexual attraction, and found no significant effect of steroid hormone levels on sexual attraction in naturally cycling women or women undergoing fertility treatment.

PSYCHONEUROENDOCRINOLOGY (2023)

Review Medicine, General & Internal

The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis

Caroline Kamp Jorgensen, Sophie Juul, Faiza Siddiqui, Mark Abie Horowitz, Joanna Moncrieff, Klaus Munkholm, Michael Pascal Hengartner, Irving Kirsch, Christian Gluud, Janus Christian Jakobsen

Summary: This study aims to assess the risks of adverse events with venlafaxine or mirtazapine in adults with major depressive disorder through systematic reviews. The effects of venlafaxine and mirtazapine will be evaluated separately in two reviews. The assessment of bias risk will be conducted using the Cochrane risk-of-bias tool version 2, and clinical significance will be assessed using an eight-step procedure. The results of this study will provide important information for the treatment of major depressive disorder.

SYSTEMATIC REVIEWS (2023)

Article Pharmacology & Pharmacy

Prevalence, trends, and individual patterns of long-term antidepressant medication use in the adult Swiss general population

Melanie A. Amrein, Michael P. Hengartner, Markus Napflin, Renato Farcher, Carola A. Huber

Summary: The study aimed to provide prevalence rates of long-term users of antidepressants in Switzerland over the last decade and investigate associated factors. The findings showed a high and steadily increasing proportion of long-term users in Switzerland, with older age, being a woman, living in an urban area, living in a nursing home, being enrolled in a standard care plan, and receiving psychiatric or psychotherapeutic care being positively associated with long-term use.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Health Care Sciences & Services

Observational studies of antidepressant use and suicide risk are selectively published in psychiatric journals

Martin Ploderl, Simone Amendola, Michael Pascal Hengartner

Summary: This study investigated whether observational studies showing favorable results for antidepressants on suicidal behavior are more likely to be published in psychiatric journals and cited more often. The study found that studies with favorable results were more frequently published in psychiatric journals and were often conducted by authors with conflicts of interest. This may create a biased evidence base within psychiatry.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2023)

Correction Primary Health Care

Swiss GPs' preferences for antidepressant treatment in mild depression: vignette-based quantitative analysis (vol 22, 261, 2021)

Michael P. Hengartner, Stefan Neuner-Jehle, Oliver Senn

BMC PRIMARY CARE (2022)

暂无数据